Outcomes at mean 5.6 years | Oest + Prog | Placebo | Hazard ratio (95% CI) |
---|---|---|---|
*CI defined in glossary. | |||
†Not significant. | |||
Cases of breast cancer (all) | 245 | 185 | 1.24 (1.02 to 1.50) |
Cases of invasive breast cancer | 199 | 150 | 1.24 (1.01 to 1.54) |
Cases of in situ breast cancer | 47 | 37 | 1.18 (0.77 to 1.82)† |